Fe₃O₄@TiO₂ Microspheres: Harnessing O₂ Release and ROS Generation for Combination CDT/PDT/PTT/Chemotherapy in Tumours

Area of Science:

• Biomaterials Science
• Nanotechnology
• Cancer Therapy

Background:

• Photodynamic therapy (PDT) is limited by low ROS yield and tumor hypoxia.
• Conventional chemotherapy faces challenges with drug resistance.
• Developing advanced nanoplatforms is crucial for overcoming these limitations.

Purpose of the Study:

• To develop a mesoporous Fe3O4@TiO2 nanoplatform for enhanced cancer therapy.
• To combine chemodynamical therapy (CDT), PDT, and photothermal therapy (PTT) with chemotherapy.
• To improve therapeutic outcomes by addressing tumor hypoxia and drug delivery.

Main Methods:

• Fabrication of mesoporous Fe3O4@TiO2 microspheres.
• Loading of the chemotherapeutic drug DOX onto the nanoplatform.
• Evaluation of the nanoplatform's properties, including magnetic targeting and drug release.
• In vitro assessment of synergistic therapeutic effects (CDT/PDT/PTT/chemotherapy).

Main Results:

• The Fe3O4@TiO2 nanoplatform effectively generated ROS and oxygen, overcoming tumor hypoxia.
• Fe3O4 catalyzed CDT by producing hydroxyl radicals.
• NIR light triggered efficient DOX release and photothermal therapy (PTT).
• The nanoplatform demonstrated good biocompatibility and synergistic anticancer effects in vitro.

Conclusions:

• The developed Fe3O4@TiO2/DOX nanoplatform offers a promising multi-modal cancer therapeutic strategy.
• This approach effectively combines CDT, PDT, PTT, and chemotherapy for enhanced tumor killing.
• The nanoplatform's magnetic targeting capability further enhances its clinical potential.